25 Jun 2026 · 1 min read
Sanofi & Pangaea to use AI for finding rare lung disease patients
Sanofi and Pangaea Data's AATD collaboration shows where pharma AI may create near-term value: finding undiagnosed patients already visible in clinical records. In rare disease, patient identification can create patient value and market expansion at the same time.